Online event
Breaking into North America’s Healthcare Market The Mysteries of Reimbursement Explained
Friday 07 November at 3:00PM
Already joined the UK Export Academy? Sign in
Discover how understanding the US reimbursement system can help your business achieve a successful healthcare product launch.
What you’ll learn
- Gain a clear understanding of how reimbursement works in the US healthcare system.
- Learn what investments and strategies are required to ensure a successful product launch in the USA.
- Understand how patient demographics and key decision-makers shape market access opportunities.
Description
The US healthcare market offers major commercial opportunities for UK companies, but without a clear understanding of the reimbursement system, even the most innovative products can struggle to gain traction. Reimbursement drives market access, pricing, and adoption, making it essential for exporters to understand how the system works and who the key stakeholders are.
By joining this webinar, you will gain insight into how reimbursement and insurance processes operate in the USA and learn what investments are needed to ensure a successful product launch. You will also explore how patient demographics influence purchasing decisions, who you need to engage within the healthcare ecosystem, and the critical questions to ask when planning your US market entry.
Speakers
Edward Dougherty
Principal, dougherty.consulting, llc
Edward Dougherty is Principal at dougherty.consulting, llc, a boutique regulatory and reimbursement consultancy in Washington, DC focused on helping medtech companies enter the US healthcare market successfully. For 30 years, Ed has worked directly with founders, company executives, board members and investors to develop an understanding of the many “healthcare markets” in the US and to prepare to take the concrete steps needed to enter their target market(s) successfully. He joins client meetings with FDA and with payer decision makers, facilitating interaction to achieve clients’ goals, and helps them position their products and services so that patients have appropriate, broad, easy access and that reimbursement is commensurate with value.
Ed works to bridge the distance between medtech entrepreneurs and the US healthcare market. He advises companies in the UK and across the EU, the Nordics, and Israel, and has authored articles about health economics and served as contributing editor to publications on global market access.